Taysha Gene Therapies, Inc.
TSHA
$3.00
$0.134.53%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 81.06% | -5.96% | -3.41% | -4.01% | 283.17% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -48.92% | 45.66% | 24.41% | 8.16% | -70.88% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -36.78% | -60.56% | -64.15% | -65.57% | -16.58% |
Total Current Assets | 77.21% | -7.57% | -5.16% | -5.97% | 229.80% |
|
|||||
Total Current Assets | 77.21% | -7.57% | -5.16% | -5.97% | 229.80% |
Net Property, Plant & Equipment | -24.40% | -23.22% | -22.26% | -22.50% | -20.43% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -4.18% | -4.73% | -3.54% | -19.38% | -17.07% |
Total Assets | 66.34% | -9.57% | -7.16% | -7.94% | 145.75% |
|
|||||
Total Accounts Payable | -11.53% | -58.32% | -43.58% | -34.41% | -19.02% |
Total Accrued Expenses | 2.93% | -24.12% | 1.34% | -17.39% | -48.72% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -0.91% | 6.60% | 14.03% | 18.01% | 7.08% |
Total Finance Division Other Current Liabilities | -53.90% | -47.06% | -42.07% | -91.76% | -29.38% |
Total Other Current Liabilities | -53.90% | -47.06% | -42.07% | -91.76% | -29.38% |
Total Current Liabilities | -25.83% | -41.62% | -28.65% | -83.74% | -32.51% |
|
|||||
Total Current Liabilities | -25.83% | -41.62% | -28.65% | -83.74% | -32.51% |
Long-Term Debt | 8.50% | 4.79% | 8.48% | 11.47% | -1.35% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -9.29% | -9.42% | -6.40% | -8.54% | -8.50% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 53.63% | 11.99% | -41.03% | -85.17% | -91.31% |
Total Liabilities | -7.56% | -15.98% | -9.16% | -62.67% | -22.87% |
|
|||||
Common Stock & APIC | 35.47% | 15.23% | 15.29% | 31.86% | 63.44% |
Retained Earnings | -16.62% | -16.16% | -17.41% | -4.06% | -25.77% |
Treasury Stock & Other | -129.06% | -810.76% | -- | -- | -- |
Total Common Equity | 128.47% | 2.25% | -4.55% | 280.80% | 393.33% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 128.47% | 2.25% | -4.55% | 280.80% | 393.33% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 128.47% | 2.25% | -4.55% | 280.80% | 393.33% |
|